Freeox Biotech
Pre-clinicalFreeox Biotech is an innovative late-stage clinical company singularly focused on the discovery and development of Cerebrovascular Protective Therapeutics. A Phase III-ready investigational drug – Ox-01, the company’s lead asset – has been shown to be an effective emergency adjunct therapy to Mechanical Thrombectomy for the treatment of Acute Ischemic Stroke (AIS). FreeOx’s leadership in this category was firmly established in early 2023, by the U.S. National Institute of Health/NINDS’ SPAN (...
About
Freeox Biotech is an innovative late-stage clinical company singularly focused on the discovery and development of Cerebrovascular Protective Therapeutics. A Phase III-ready investigational drug – Ox-01, the company’s lead asset – has been shown to be an effective emergency adjunct therapy to Mechanical Thrombectomy for the treatment of Acute Ischemic Stroke (AIS). FreeOx’s leadership in this category was firmly established in early 2023, by the U.S. National Institute of Health/NINDS’ SPAN (...
Company Info
Contact
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile